Hear From Allen, a Stage IV Survivor of a Deadly Head & Neck Cancer

Allen pushed for access to advanced molecular testing which identified a mutation that could be targeted with a prostate cancer therapy that ultimately saved his life.

Please click on the video link below to hear Allen’s two minute story and why he participated in CCRAN’s Biomarker Conference!

CCSN attend as a panelist to the patient group roundtable at CCRAN’s biomarker conference. It was an honour to be asked to sit on the panel amongst the other patient groups to address the current issues patients are facing regarding access to biomarker testing.